MAP1LC3A and cancer: LC3 is a core autophagy‐related protein, and when autophagy is formed, the cytoplasmic form of LC3 (LC3 I) enzymatically cleaves a small polypeptide and converts to the membranous form (LC3 II).[21] To explore the occurrence of autophagy in cancer cells treated with various treatments, it was found that the expression of LC3 II was significantly increased in 786‐O cells treated with APm/Ce6+US compared with that in cells treated with APm/Ce6/HIF+US by western blot.